Outcomes of beta blockers (BB) in hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Wu, Linda
Ozbek, Umut
van Hyfte, Grace
Reincke, Marlene
Gampa, Anuhya
Abugabal, Yehia I.
Nishida, Naoshi
Wietharn, Brooke
Amara, Suneetha
Balcar, Lorenz
Pinter, Matthias
Vogel, Arndt
Weinmann, Arndt
Saeed, Anwaar
Rimassa, Lorenza
Naqash, Abdul Rafeh
Muzaffar, Mahvish
Huang, Yi-Hsiang
Pinato, David James
Ang, Celina
机构：
[1] Mt Sinai Hosp, Tisch Canc Inst, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Mt Sinai Hosp, New York, NY 10029 USA
[4] Univ Freiburg, Fac Med, Med Ctr, Freiburg, Germany
[5] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Kindai Univ, Osaka, Japan
[8] Univ Kansas, Sch Med, Kansas City, KS USA
[9] East Carolina Univ, Greenville, NC 27858 USA
[10] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[11] Med Univ Vienna, Vienna, Austria
[12] Hannover Med Sch, Hannover, Germany
[13] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Mainz, Germany
[14] Kansas Univ, Canc Ctr, Kansas City, KS USA
[15] Humanitas Univ, Pieve Emanuele & Humanitas Canc Ctr, IRCCS Humanitas Res Hosp, Dept Biomed Sci, Milan, Italy
[16] NCI, Dev Therapeut Clin, Early Clin Trials Dev Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[17] East Carolina Univ, Vidant Canc Ctr, Greenville, NC 27858 USA
[18] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Inst Clin Med, Div Gastroenterol & Hepatol, Taipei, Taiwan
[19] Imperial Coll, Dept Surg & Canc, London, England
[20] Mt Sinai Hosp, Tisch Canc Inst, Dept Med, Div Hematol Oncol, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.399
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
399
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
    van Doorn, Diederick J.
    Takkenberg, Robert Bart
    Klumpen, Heinz-Josef
    [J]. PHARMACEUTICALS, 2021, 14 (01) : 1 - 23
  • [22] Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
    Rujia Zhang
    Haoran Zhao
    Peng Wang
    Zuoming Guo
    Chunxun Liu
    Zhaowei Qu
    [J]. BMC Cancer, 23
  • [23] PREDICTING EARLY HEPATIC DECOMPENSATION AND DEATH IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: THE HCC- AIM SCORE
    Li, Michael
    Kelley, Kate
    Mehta, Neil
    Yao, Francis
    Fong, Lawrence
    Lai, Jennifer C.
    [J]. HEPATOLOGY, 2023, 78 : S1871 - S1871
  • [24] Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
    Zhang, Rujia
    Zhao, Haoran
    Wang, Peng
    Guo, Zuoming
    Liu, Chunxun
    Qu, Zhaowei
    [J]. BMC CANCER, 2023, 23 (01)
  • [25] Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma (aRCC) treated with immune checkpoint inhibitors (ICIs)
    Yildirim, Ahmet
    Wei, Mengting
    Liu, Yuan
    Goswamy, Rohit Vivek
    Choi, Yujin
    Brown, Jacqueline T.
    Nazha, Bassel
    Martini, Dylan J.
    Hartman, Caitlin
    McClintock, Greta Russler
    Zhuang, Tony
    Kissick, Haydn
    Harris, Wayne B.
    Carthon, Bradley Curtis
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Diabetes Induced by Immune Checkpoint Inhibitors (ICIs)
    Verges, Bruno
    [J]. ANNALES D ENDOCRINOLOGIE, 2023, 84 (03) : 351 - 351
  • [27] Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity
    Zarifa, Abdulrazzak
    Lopez-Mattei, Juan
    Palaskas, Nicolas
    Iliescu, Cezar
    Durand, Jean-Bernard
    Kim, Peter Y.
    [J]. IMMUNOTHERAPY, 3RD EDITION, 2020, 1244 : 277 - 285
  • [28] Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort
    D'Aiello, Angelica
    Lin, Juan
    Gucalp, Rasim
    Tabatabaie, Vafa
    Cheng, Haiying
    Bloomgarden, Noah A.
    Tomer, Yaron
    Halmos, Balazs
    [J]. CANCERS, 2021, 13 (06)
  • [29] Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review
    Baltussen, Joosje C.
    Welters, Marij J. P.
    Verdegaal, Elizabeth M. E.
    Kapiteijn, Ellen
    Schrader, Anne M. R.
    Slingerland, Marije
    Liefers, Gerrit-Jan
    van der Burg, Sjoerd H.
    Portielje, Johanneke E. A.
    de Glas, Nienke A.
    [J]. CANCERS, 2021, 13 (24)
  • [30] Impact of timing of antibiotic use on clinical outcomes in patients with urothelial cancer treated with immune checkpoint inhibitors (ICIs).
    Weinstock, Chana
    Bandaru, Pradeep
    Fernandes, Laura L.
    Chang, Elaine
    Girvin, Andrew
    Tang, Shenghui
    Agrawal, Sundeep
    Suzman, Daniel L.
    Singh, Harpreet
    Brave, Michael Holman
    Xu, James
    Goldberg, Kirsten B.
    Ibrahim, Amna
    Theoret, Marc Robert
    Pazdur, Richard
    Beaver, Julia A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345